6 min read
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A true testimony that we sit at the intersection of significant new opportunities The significant opportunities at the intersection of
Tag : As And Partnerships
6 min read
6 min read
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A True Testimony that we Sit at The Intersection of Significant New Opportunities The significant opportunities at the intersection of
Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology
EEL assay overcomes well-known limitations in spatial biology SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Rebus Biosystems Inc, (“Rebus
Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology
EEL assay overcomes well-known limitations in spatial biology SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Rebus Biosystems Inc, (“Rebus
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patients MENLO
1 min read
Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars
One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with
Genoox and Aspira Women’s Health Inc. Partner to Develop and Deliver Data-Driven Insights to Advance Women’s Health
This partnership will expand on the information currently available to establish and improve advanced testing to accurately diagnose complex diseases
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
Monday, September 20, 2021 Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing
Latest Strategic Initiatives Solidify Genome Medical as Clear Digital Genetic Health Leader Financing Led by Casdin Capital with Participation from
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
Aug 18, 2021GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO, /PRNewswire/ — Illumina,
HiberCell Expands Translational Oncology Toolbox by Acquiring Genuity Science, Inc.
Deal strengthens HiberCell’s balance sheet, accelerates clinical programs and expands pre-clinical pipeline through the integration of next
Fulgent Genetics Announces Acquisition of CSI Laboratories
August 09, 2021 04:02 PM Eastern Daylight Time TEMPLE CITY, Calif.–(BUSINESS WIRE)–Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the
Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company
Technology Will Enable Continued End-to-End Automated Workflow Development MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
Tuesday, July 20, 2021 Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical
Pacific Biosciences and RCIGM Announce its First Collaboration for Whole Genome Sequencing Research
June 23, 2021 HiFi Sequencing will be used on a cohort of rare disease cases with the aim to identify numerous variants, both small and structural,